Keyphrases
SARS-CoV-2 Lineages
50%
Coronavirus
50%
Lineage B.1.1.7
50%
DNA Genome
50%
Genome Analysis
50%
Aalborg
37%
Epidemic Control
25%
BA.4
16%
Omicron BA.1
16%
Variant Identification
16%
SARS-CoV-2 RT-qPCR
16%
Mutation Calling
16%
BA.2
16%
Novel Coronavirus SARS-CoV-2
16%
RT-qPCR Diagnostics
16%
BA.2.75
16%
Complete Genome Sequence
12%
Sequence Information
12%
DNA Analysis
12%
Life Sciences
12%
Public Authorities
12%
Special Responsibilities
12%
Vaccine Development
12%
Press Releases
12%
Chemistry Departments
12%
Time-scaled Phylogeny
12%
Close Proximity
12%
Unmonitored
12%
Comprehensive Surveillance
12%
Genetic Material
12%
Emerging Variants
12%
Travel Restrictions
12%
Decision Support
12%
Virus Spread
12%
University Hospital
12%
Transmissibility Function
10%
New Lineage
10%
Alpha Variant
10%
RT-PCR Testing
8%
COVID-19 Surveillance
8%
Hospital Preparedness
8%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
59%
Infection
50%
Cohort Study
50%
Coronavirinae
50%
Genome Analysis
50%
Reverse Transcription Polymerase Chain Reaction
28%
Whole Genome Sequencing
19%
Phylogeny
16%
Contact Examination
16%
DNA Determination
12%
Decision Making
12%
Surveillance System
7%
Diseases
7%
Population Research
7%
Virus Genome
7%
Patient Registry
7%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Coronavirinae
60%
Lineages
50%
Viral Load
50%
Spike
50%
Sanger Sequencing
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
30%
Whole Genome Sequencing
12%
Decision Making
12%
Vaccine Efficacy
12%
Genome Sequencing
10%
Omicron Coronavirus Variant
10%
Monospecific Antibody
10%
Amplicon
10%
Turnaround Time
10%
Neutralizing Antibody
7%